Pages that link to "Q35371321"
Jump to navigation
Jump to search
The following pages link to Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables (Q35371321):
Displaying 25 items.
- Autonomic dysfunction in early breast cancer: Incidence, clinical importance, and underlying mechanisms (Q26795624) (← links)
- Assessing the Cardiac Toxicity of Chemotherapeutic Agents: Role of Echocardiography (Q30446509) (← links)
- Early detection of doxorubicin cardiomyopathy using two-dimensional strain echocardiography (Q30491590) (← links)
- Cancer therapy and cardiotoxicity: the need of serial Doppler echocardiography. (Q30500830) (← links)
- Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade (Q31863935) (← links)
- Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis. (Q34535269) (← links)
- Trastuzumab-associated cardiotoxicity (Q34867708) (← links)
- Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques. (Q35580102) (← links)
- Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis (Q35934224) (← links)
- Cardiovascular toxicity caused by cancer treatment: strategies for early detection (Q37430831) (← links)
- Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies (Q37998724) (← links)
- Vasovagal tonus index (VVTI) as an indirect assessment of remission status in canine multicentric lymphoma undergoing multi-drug chemotherapy (Q38632791) (← links)
- Non-Invasive Functional and Biochemical Assessment of Mitoxantrone Cardiotoxicity in Patients with Multiple Sclerosis (Q44630598) (← links)
- Utility of prechemotherapy echocardiographical assessment of cardiac abnormalities. (Q51530456) (← links)
- Autonomic nervous system and cancer. (Q52623821) (← links)
- Early mitoxantrone-induced cardiotoxicity in secondary progressive multiple sclerosis (Q56986554) (← links)
- Early diastolic strain rate measurements by cardiac MRI in breast cancer patients treated with trastuzumab: a longitudinal study (Q58616457) (← links)
- Role of Endothelium in Doxorubicin-Induced Cardiomyopathy (Q60924005) (← links)
- Impairment of heart rate variability control during arsenic trioxide treatment for acute promyelocytic leukemia (Q79362741) (← links)
- Recovery kinetics of heart rate and oxygen uptake in long-term survivors of acute leukemia in childhood (Q80079704) (← links)
- Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults (Q80488535) (← links)
- Topoisomerase II inhibitors (Q80510502) (← links)
- Low-dose anthracyclines in childhood Acute Lymphoblastic Leukemia (ALL): no cardiac deterioration more than 20 years post-treatment (Q81688025) (← links)
- Cardiac autonomic modulation impairments in advanced breast cancer patients (Q88551117) (← links)
- Cardiovascular Autonomic Dysfunction in Patients with Cancer (Q89414672) (← links)